Hims & Hers Health (NYSE:HIMS) Raised to “Buy” at Wall Street Zen

Hims & Hers Health (NYSE:HIMS) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Sunday.

A number of other research analysts also recently commented on HIMS. TD Cowen downgraded Hims & Hers Health from a “buy” rating to a “hold” rating and dropped their price target for the company from $44.00 to $30.00 in a research note on Tuesday, April 29th. Truist Financial upped their price objective on Hims & Hers Health from $45.00 to $48.00 and gave the stock a “hold” rating in a research report on Thursday, July 17th. UBS Group set a $30.00 target price on shares of Hims & Hers Health in a research note on Monday, June 23rd. Bank of America raised their price objective on shares of Hims & Hers Health from $22.00 to $26.00 and gave the company an “underperform” rating in a report on Tuesday, April 29th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Hims & Hers Health currently has an average rating of “Hold” and a consensus price target of $39.83.

Hims & Hers Health Stock Down 5.4%

Shares of NYSE HIMS opened at $47.66 on Friday. Hims & Hers Health has a twelve month low of $13.47 and a twelve month high of $72.98. The company’s fifty day moving average is $53.82 and its 200-day moving average is $42.04. The stock has a market cap of $10.67 billion, a price-to-earnings ratio of 69.07, a P/E/G ratio of 1.85 and a beta of 2.02.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings data on Monday, May 5th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.12 by $0.08. The business had revenue of $586.01 million for the quarter, compared to analysts’ expectations of $535.21 million. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm’s revenue was up 110.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.05 EPS. On average, research analysts anticipate that Hims & Hers Health will post 0.29 EPS for the current fiscal year.

Insider Buying and Selling at Hims & Hers Health

In related news, insider Michael Chi sold 17,102 shares of the firm’s stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total value of $1,021,844.50. Following the sale, the insider directly owned 278,654 shares of the company’s stock, valued at $16,649,576.50. This trade represents a 5.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Soleil Boughton sold 2,572 shares of the business’s stock in a transaction on Monday, July 14th. The shares were sold at an average price of $47.82, for a total transaction of $122,993.04. Following the sale, the insider owned 158,165 shares in the company, valued at approximately $7,563,450.30. This trade represents a 1.60% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 647,183 shares of company stock valued at $35,310,366. Company insiders own 17.71% of the company’s stock.

Institutional Investors Weigh In On Hims & Hers Health

Institutional investors have recently modified their holdings of the business. Raymond James Financial Inc. purchased a new position in shares of Hims & Hers Health during the 4th quarter worth $18,048,000. O Shaughnessy Asset Management LLC bought a new position in Hims & Hers Health in the 4th quarter worth $208,000. Commonwealth Equity Services LLC lifted its position in Hims & Hers Health by 111.6% during the fourth quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company’s stock valued at $1,424,000 after purchasing an additional 31,062 shares in the last quarter. GAMMA Investing LLC grew its holdings in Hims & Hers Health by 128.5% during the first quarter. GAMMA Investing LLC now owns 5,143 shares of the company’s stock valued at $152,000 after purchasing an additional 2,892 shares during the period. Finally, New York State Teachers Retirement System increased its position in Hims & Hers Health by 95.2% in the first quarter. New York State Teachers Retirement System now owns 194,795 shares of the company’s stock worth $5,756,000 after buying an additional 94,983 shares in the last quarter. 63.52% of the stock is owned by hedge funds and other institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.